Screener
DBV Technologies DBVT Expenses by function — Research and development expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by DBV Technologies in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: DBV Technologies’s 10-Q, filed July 16, 2026.
- Filed
- Jul 16, 2026, 4:08 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-048453
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Research and Development expenses | 9.4 | 5.7 | 17.9 | 10.3 |
| Sales & Marketing expenses | 2.2 | 0.2 | 3.2 | 0.4 |
| General & Administrative expenses | 6.4 | 3.9 | 11.0 | 6.9 |
| Total personnel expenses | 18.0 | 9.8 | 32.0 | 17.6 |
Item 1C. Condensed Consolidated Statements of Financial Position (Unaudited) as of
FAQ
- What is DBV Technologies's expenses by function — research and development expense?
- DBV Technologies (DBVT) reported expenses by function — research and development expense of $9.4M in Q2 2026.
- How has DBV Technologies's expenses by function — research and development expense changed year-over-year?
- DBV Technologies's expenses by function — research and development expense increased by 64.9% year-over-year, from $5.7M to $9.4M.
- What is the long-term trend for DBV Technologies's expenses by function — research and development expense?
- Over 4 years (2021 to 2025), DBV Technologies's expenses by function — research and development expense has grown at a 11.7% compound annual growth rate (CAGR), from $14.6M to $22.76M.
- What does expenses by function — research and development expense mean?
- This metric represents the total costs incurred by the company for research and development activities, including clinical trials, laboratory testing, and the development of proprietary technology platforms. It reflects the investment intensity in the company's pipeline and its commitment to advancing therapeutic candidates through regulatory stages. Investors use this to assess the company's long-term innovation potential and the capital required to reach commercialization.
Ask your AI about DBV Technologies's expenses by function — research and development expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude